Ingunn Munch Lindvig
Fortune : - $ au 31/08/2026
Fortune : - $ au 31/08/2026
Ingunn Munch Lindvig is currently the Senior Vice President-Regulatory Affairs at BioInvent International AB since 2023.
Previously, she worked as the Head-Regulatory Affairs at Nordic Nanovector ASA and as the Vice President & Head-Regulatory Affairs at Circio Holding ASA. Dr. Lindvig holds a doctorate degree from the University of Oslo.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/12/2025 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| BIOINVENT INTERNATIONAL AB | Conseiller Juridique Général | 12/06/2023 |
| Sociétés | Poste | Fin |
|---|---|---|
| THOR MEDICAL | Conseiller Juridique Général | - |
| CIRCIO HOLDING ASA | Conseiller Juridique Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
BioInvent International AB
BioInvent International AB BiotechnologyHealth Technology Develops and manufactures immunomodulatory antibodies for cancer treatment | Health Technology |
University of Oslo
University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nordic Nanovector ASA
Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Develops innovative anticancer therapeutics | Health Technology |
Circio Holding ASA
Circio Holding ASA BiotechnologyHealth Technology Develops active immunotherapy cancer vaccines | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national